NEW joint pain supplement launched at Vitafoods Europe

Written by PharmaLinea.

Next-generation joint health product

At Vitafoods Europe 2024, PharmaLinea will reveal the latest addition to its portfolio of clinically supported private label nutraceuticals. >Your< Arthro Ease Capsules is a clinically studied next-generation product for the relief of joint pain and ease of movement. Its advanced formulation features several modes of action for the regeneration of damaged cartilage tissue, anti-inflammatory effects, and relief of pain. The resulting complex has been clinically shown to be highly efficient at reducing joint pain severity, discomfort, swelling, and stiffness, as well as restoring joint functionality both in osteoarthritis and lower back pain sufferers.

>Your< Arthro Ease Capsules contain undenatured type II collagen, Boswellia extract, MSM, and Vitamins C and D3. Its design is representative of a new wave of joint health products. Traditional supplements for joint health featured large doses of powders with ingredients like chondroitin, glucosamine, and hydrolyzed collagen, which were primarily meant as building blocks for the regeneration of cartilage. Advanced, recently launched products tend to include undenatured type II collagen (which triggers an immune response that cleans worn-out joint tissue, allowing new tissue to be formed) and ingredients like Boswellia and MSM (which have anti-inflammatory and pain-reducing effects). The consequence is a lower dose (just 1 capsule), a multimodal mode of action, and a much more tangible efficacy in reducing pain and swelling, as well as restoring joint functionality. The latter was demonstrated by >Your< Arthro Ease Capsules in three clinical trials on the finished product.

Clinical studies on the finished product

Three clinical trials performed on the product have already been published and they show significant improvements in pain and mobility in knee osteoarthritis and lower back pain patients.

The first study was a multicenter, double-blind, placebo-controlled, randomized study on 212 patients with stage 2–3 primary osteoarthritis of the knee joint. For 6 months, group 1 received >Your< Arthro Ease Capsules and a rescue drug on demand, while group 2 received placebo capsules and a rescue drug on demand. After only 2 months, group 1 demonstrated a 92% higher decrease in pain severity (WOMAC score) when compared to placebo.

The second study was an open, randomized, prospective study on 70 patients with osteoarthritis and stage 1–3 knee joint damage. For 6 months, group 1 received >Your< Arthro Ease Capsules and a rescue drug on demand, while group 2 received a comparator product, representative of more classic joint health products (a combination of chondroitin and glucosamine), and a rescue drug on demand. The study examined various indicators of knee osteoarthritis severity, including the surface area of synovitis (swelling in the knee joint). >Your< Arthro Ease Capsules produced more than double the synovitis reduction rate of the chondroitin + glucosamine combination.

The third study was an open randomized observational study on 60 patients with chronic nonspecific pain in the lower back. Group 1 received >Your< Arthro Ease Capsules (for 120 days), an NSAID analgesic Meloxicam (for 10 days), and exercise therapy. Group 2 received only the NSAID analgesic Meloxicam (for 10 days) and exercise therapy. >Your< Arthro Ease Capsules in combination with the analgesic were up to 33% more effective in reducing pain severity (VAS scale) after 4 months, compared to the group taking the analgesic alone.

Ready to launch

>Your< Arthro Ease Capsules are ready to be launched under your own brand in your market. Aside from the supplement itself, the product includes a robust set of clinical data that can be used for promotion to doctors, pharmacists, and consumers. As was already proven by one of our clients, who launched the product in their market in the CIS region, >Your< Arthro Ease Capsules are able to stand out in the market, convince doctors such as rheumatologists, and provide substantial sell-out results. Visit PharmaLinea’s stand K110 at Vitafoods Europe to find out more details.

Content provided by PharmaLinea.